Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 16 most recent Form 4 transactions.
| PCVX |
| Vaxcyte, Inc. |
| FTAX |
| 361 |
| $60.74 |
| $21.9K |
| -0.5% |
| Open the original filing on SEC.gov |
| Aug 5 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 17,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 5 | PCVX | Vaxcyte, Inc. | SSELL◷ | 17,000 | $55.00 | $935.1K | -18.1% | Open the original filing on SEC.gov |
| Aug 5 | PCVX | Vaxcyte, Inc. | MEXER◷ | 17,000 | $24.79 | $421.4K | +22.1% | Open the original filing on SEC.gov |
| Mar 9 | PCVX | Vaxcyte, Inc. | FTAX | 604 | $59.32 | $35.8K | -0.8% | Open the original filing on SEC.gov |
| Mar 2 | PCVX | Vaxcyte, Inc. | FTAX | 465 | $61.98 | $28.8K | -0.6% | Open the original filing on SEC.gov |
| Feb 28 | PCVX | Vaxcyte, Inc. | FTAX | 292 | $61.98 | $18.1K | -0.4% | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT◆ | 46,424 | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT | 53,409 | — | — | +223.2% | Open the original filing on SEC.gov |
| Dec 31, 2025 | PCVX | Vaxcyte, Inc. | SSELL | 9,743 | $46.69 | $454.9K | -28.9% | Open the original filing on SEC.gov |
| Sep 8, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 1,204 | $32.41 | $39K | -3.5% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 464 | $31.56 | $14.6K | -1.3% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 783 | $31.56 | $24.7K | -2.2% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 291 | $31.56 | $9.2K | -0.8% | Open the original filing on SEC.gov |